Markets

Health Care Sector Update for 12/14/2015: KANG,NRX,ATRA

Top Health Care Stocks

JNJ +0.22%

PZE -0.28%

MRK +0.72%

ABT -0.21%

AMGN +1.37%

Health care stocks were narrowly mixed this afternoon, with the NYSE Health Care Index slipping around 0.1% while shares of health care companies in the S&P 500 were up about 0.1% as a group.

In company news, American depository shares of iKang Healthcare Group ( KANG ) were hanging on to a small gain this afternoon after an investor group that includes one of the Chinese laboratory services company's top rivals increased their buyout offer by over 7%.

The new, $23.50-per-ADS offer is $1.50 higher than the group's Nov. 29 bid. At the time, iKang slammed the offer as "malicious," saying rival Meinian Onehealth was largely trying to disrupt the company's proposed going-private transaction announced in late August. iKang later adopted a so-called poison pill rights plan to thwart the Meinian bid and founder and board chairman Zhang Ligang reportedly vowed to never sell his shares to a third-party.

KANG shares were up almost 1% at $19.52 apiece, earlier climbing to a session high of $20.13 a share.

In other sector news,

(+) NRX, Receives FDA clearance of its Investigational New Drug application for a clinical trial of its intravenous pyridorin product candidate for treating acute kidney injury.

(-) ATRA, Said its PINTA 745 drug candidate failed to meet primary target during Phase II proof-of-concept trial to treat protein-energy wasting in patients with end-stage kidney disease.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Commodities

Latest Markets Videos